A vial with the Johnson & Johnson’s one-dose COVID-19 vaccine is seen at the Vaxmobile, at the Uniondale Hempstead Senior Center, Wednesday, March 31, 2021, in Uniondale, N.Y. THE CANADIAN PRESS/AP/Mary Altaffer

A vial with the Johnson & Johnson’s one-dose COVID-19 vaccine is seen at the Vaxmobile, at the Uniondale Hempstead Senior Center, Wednesday, March 31, 2021, in Uniondale, N.Y. THE CANADIAN PRESS/AP/Mary Altaffer

What we know about J&J’s single-dose vaccine, set to arrive at the end of April

Canada approved the vaccine in early March and had pre-ordered 10 million doses

Canada will soon add another COVID-19 vaccine to its supply, with procurement minister Anita Anand announcing this week that initial shipments of Johnson & Johnson’s single-dose jab are to arrive by the end of April.

Canada approved the vaccine in early March and had pre-ordered 10 million doses, but manufacturing problems from the company led to shipment delays to Canada and elsewhere.

Anand did not have details when she made her announcement Tuesday about how many doses would be included in the first shipment.

Johnson & Johnson gives Canada four distinct vaccines — along with Pfizer-BioNTech, Moderna and Oxford-AstraZeneca — and its one-and-done element adds flexibility to the country’s plan to immunize the majority of its residents by September.

Dr. Sumon Chakrabarti, an infectious disease expert in Mississauga, Ont., says that while the vaccines are arriving later than expected, they’ll be a welcome addition to Canada’s rollout.

“A single-dose vaccine, as well as the fact it only requires a regular fridge (to store it), that is so huge in terms of taking this vaccine and bringing it to targeted populations,” he said. “I wish it was (arriving before) the end of April, but I’ll take it.”

Johnson & Johnson hit another manufacturing bump Wednesday, announcing that a batch of its vaccine had failed quality standards and can’t be used.

The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries.

Here’s what we know about Johnson & Johnson’s vaccine:

HOW EFFECTIVE IS IT?

Johnson & Johnson announced promising results from its Phase 3 clinical trials at the end of January, suggesting its vaccine reduced severe COVID-19 disease by 85 per cent, and prevented 100 per cent of COVID-related hospitalization or death.

The vaccine had a 72 per cent efficacy in preventing COVID infections after 28 days in the company’s U.S. trials. The efficacy dropped to 66 per cent when averaging in results from other global trials, including a South African study that factored in more transmissible variants of the COVID virus.

Pfizer and Moderna showed 95 per cent efficacy in their respective trials, but those were tested against previous dominant strains and didn’t account for variants that have popped up since.

Pfizer, Moderna and AstraZeneca also had zero hospitalizations and deaths in their trials.

Chakrabarti says it’s important to distinguish the timing of the four trials, and stressed that they all work exceedingly well the metrics that matter most.

“All four of these vaccines … are exceptionally effective at preventing hospitalization and death,” he said. “Those are the two things that we care about.”

WHAT ARE THE BENEFITS OF THIS VACCINE?

The ease of distribution offered by a single-dose shot — unlike the two-dose vaccines from Pfizer, Moderna and AstraZeneca — and its ability to be stored in a regular fridge are among Johnson & Johnson’s biggest strengths.

Pfizer’s vaccine initially required ultra-cold storage temperatures between -60 C and -80 C, though Health Canada recently said it could be stored in a regular freezer for up to 14 days. Moderna’s vaccine can also be stored at regular freezer temperatures while AstraZeneca can be stored in a fridge.

Chakrabarti says Johnson & Johnson’s product is conducive to large, mobile vaccine clinics that can be set up quickly to target populations in hard-hit communities, especially essential workers.

“You can transport the vaccine there and just boom, boom, boom, get it into people’s arms,” he said. “The timing doesn’t help — we really wanted to start (vaccinating) essential workers as quickly as possible … But it’s something you can do (easily) with J&J.”

Chakrabarti added that Johnson & Johnson may also benefit from not having the string of confusing messaging surrounding it that AstraZeneca has had.

Canada’s National Advisory Committee on Immunization (NACI) has set age recommendations on AstraZeneca three times. The latest recommendation is to pause the use of AstraZeneca in those under 55 due to rare blood clot links that were observed in Europe.

READ MORE: Trudeau says Johnson & Johnson vaccine faces production challenges

Omar Khan, an assistant professor in biomedical engineering at the University of Toronto, says Johnson & Johnson could slot into the void left by provinces not using AstraZeneca on those under 55.

“That (decision by NACI) effectively reduced our vaccine supply,” Khan said. “But with this we can make up that loss of supply for that population and hopefully get us back on track.”

The fact that Johnson & Johnson is already in use in the U.S. may give Canadians more confidence in it, Chakrabarti says.

The FDA authorized Johnson & Johnson on Feb. 27 for emergency use — just as it had for Pfizer and Moderna in December — but shipments to the U.S. were also affected by manufacturing problems early on. The bulk of vaccine use in the U.S. has been Pfizer and Moderna.

“It’s very good when you see other countries having experience with it,” he said, adding that a mountain of positive AstraZeneca data also exists from the U.K., as well as data from Israel on the high effectiveness of Pfizer.

WHAT KIND OF VACCINE TECHNOLOGY IS USED?

Unlike the mRNA used in Pfizer and Moderna’s products, Johnson & Johnson is a non-replicating viral vector vaccine similar to AstraZeneca’s.

That means it uses a different harmless virus, which can’t copy itself, as a vector to give our cells the instructions they need to make the coronavirus’s spike protein.

The immune system recognizes the protein and makes antibodies, which then allow us to fend off attack if exposed in the future.

Khan says it takes a couple weeks for the body to build up immunity with any of the vaccines, but those receiving Johnson & Johnson should especially take note of that.

“Yes, it’s one dose so people might say ‘one and done, ready to go,’ but you still need to give yourself the bare minimum two weeks,” he said. “Ideally, give yourself a month, and then you’ll have a higher level of protection.”

Melissa Couto Zuber, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

A Google Earth image of a well site in Ponoka County from WellWiki.org.
Website ‘WellWiki.org’ makes accessing local well site information easy and accessible

U of A professor developed the database of well sites, including Ponoka County

Dr. Wayne John Edwards, 66, died Tuesday at Chinook Regional Hospital. (Cornerstone Funeral Home)
Lethbridge doctor becomes 7th Alberta health-care worker to die from COVID-19

Dr. Wayne John Edwards, who was 66, died Tuesday at the Chinook Regional Hospital in the southern Alberta city

Conservative leader Erin O’Toole holds a press conference on Parliament Hill in Ottawa on Tuesday, April 6, 2020. Top Tory leaders of past and present will speak with supporters today about what a conservative economic recovery from COVID-19 could look like. THE CANADIAN PRESS/Sean Kilpatrick
O’Toole to vote against Conservative MP’s private bill on ‘sex-selective abortion’

Erin O’Toole said he supports a woman’s right to choose and will personally vote against the private member’s bill

Doses of the Moderna COVID‑19 vaccine in a freezer trailer, to be transported to Canada during the COVID-19 pandemic. THE CANADIAN PRESS/Nathan Denette
Pfizer to increase vaccine deliveries in Canada as Moderna supply slashed

Moderna plans to ship 650,000 doses of its vaccine to Canada by the end of the month, instead of the expected 1.2 million

A empty classroom is pictured at Eric Hamber Secondary school in Vancouver, B.C. Monday, March 23, 2020. The Alberta government says schools in Calgary will move to at-home learning starting Monday for students in grades 7 to 12.THE CANADIAN PRESS/Jonathan Hayward
Calgary schools to shift to at-home learning for grades 7 to 12 due to COVID-19

The change, due to COVID-19, is to last for two weeks

A man wears a protective face covering to help prevent the spread of COVID-19 as he walks past the emergency entrance of Vancouver General Hospital in Vancouver, B.C., Friday, April 9, 2021. THE CANADIAN PRESS/Jonathan Hayward
COVID-19 spike in B.C. could overwhelm B.C. hospitals: modelling group

There are 397 people are in hospital due to the virus, surpassing a previous high of 374 seen in December

Ron Rauch and his wife Audrey are photographed at their home in Victoria, Friday, March 5, 2021. Their daughter Lisa Rauch died on Christmas Day 2019 when a tactical officer with the Victoria Police Department shot her in the back of the head with plastic bullets after barricading herself in a room that was on fire. THE CANADIAN PRESS/Chad Hipolito
B.C. families push for changes as special committee examines provincial Police Act

Solicitor General Mike Farnworth acknowledged the need to update the legislation last year

Major-General Dany Fortin, left, looks on as Minister of Public Services and Procurement Anita Anand provides an update on the COVID-19 pandemic, in Ottawa, Tuesday, Dec. 15, 2020. The Public Health Agency of Canada has set aside up to $5 billion to pay for COVID-19 vaccines. THE CANADIAN PRESS/Sean Kilpatrick
Canada negotiating contracts to secure COVID-19 booster shots for next year: Anand

Most of Canada’s current vaccine suppliers are already testing new versions against variants

(Government of Canada)
Liberal MP caught stark naked during House of Commons video conference

William Amos, in Quebec, appeared on the screens of his fellow members of Parliament completely naked

Health Canada headquarters in Ottawa. (Sean Kilpatrick/The Canadian Press)
Health Canada releases guidelines for reducing COVID-19 transmission at home

Improve indoor air quality by opening up your windows and doors, among other encouraged ventilation measures

Alberta Premier Jason Kenney updates media on measures taken to help with COVID-19, in Edmonton on Friday, March 20, 2020. Alberta is set to join three other provinces in exploring the feasibility of small modular reactors as a clean energy option. THE CANADIAN PRESS/Jason Franson
Four provinces to sign memorandum of understanding to explore small nuclear reactors

Alberta government said in August that it would enter into the agreement to help diversify its energy sector

Most Read